It is also believed to have antiatherosclerotic properties, as studies in Israel have shown that the fruit juice, taken daily, prevented the thickening of arteries and slowed down cholesterol oxidation by almost half (Clin Nutr. 2004 Jun;23(3):423-33).
Researchers from the University of California’s non-profit Preventive Medicine Research Institute and California Pacific Medical Center claim their new study, published in the September 16 issue of the Journal of Cardiology, is the first to assess its effect on patients with ischemic coronary heart disease (CHD).They randomly divided 45 participants, all of whom had CHD and myocardial ischemia, into two groups. One group received 250ml (8.5 oz) pomegranate juice each day for three months, and the other received the same amount of a placebo drink with a similar calorific content, flavor and color.
Their findings showed that blood flow to the heart improved by about 17 percent in the pomegranate group and declined by 18 percent in the placebo group. The researchers noted that this benefit was realized without and negative effects on lipids, blood glucose, hemoglobin A1c, body weight or blood pressure.
Senior author Dean Ornish said: "Although the sample in this study was relatively small, the strength of the design and the significant improvements in blood flow to the heart observed after only three months suggest that pomegranate juice may have important clinical benefits in those with coronary heart disease."
No comments:
Post a Comment